中文名稱:阿尼魯單抗 | 英文名稱:Research Grade Anifrolumab(DHD23001) |
CAS:1326232-46-5 | 純度規(guī)格: PAGE:>95% |
產(chǎn)品類別: 藥物對照抗體 | |
抗體名: Anifrolumab | 靶點: Interferon alpha/beta receptor 1, Cytokine receptor family 2 member 1, Cytokine receptor class-II member 1, CRF2-1, IFN-R-1, IFNAR1, IFNAR, IFN-alpha/beta receptor 1, Type I interferon receptor 1 |
宿主: Homo sapiens | 適應物種: Human |
克隆性: Monoclonal | 藥物對照抗體: Anifrolumab |
Tags:Anifrolumab 代理商,Anifrolumab 價格,Anifrolumab 供應商, Anifrolumab supplier,Anifrolumab purchase,Anifrolumab 購買,Anifrolumab 銷售
Catalog No.
DHD23001
Host species
Homo sapiens
Species reactivity
Human
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Concentration
1 mg/ml
Purity
>95%
Clonality
Monoclonal
Isotype
IgG1-kappa
Applications
Research Grade Biosimilar
Target
Interferon alpha/beta receptor 1, Cytokine receptor family 2 member 1, Cytokine receptor class-II member 1, CRF2-1, IFN-R-1, IFNAR1, IFNAR, IFN-alpha/beta receptor 1, Type I interferon receptor 1
Purification
Protein A or G purified from cell culture supernatant.
Endotoxin level
Please contact with the lab for this information.
Expression system
XtenCHO
Accession
P17181
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Alternative Names
MDX-1333, MEDI-546, CAS: 1326232-46-5
Note
For research use only. Not suitable for clinical or therapeutic use.
成立日期 | 2021-04-08 (4年) | 注冊資本 | 一千萬元人民幣 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1000萬-5000萬 |
主營行業(yè) | 生物化工,技術服務 | 經(jīng)營模式 | 試劑 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP3年
|
湖北魏氏化學試劑股份有限公司
|
2024-12-26 | |
¥50000 |
VIP5年
|
武漢維斯爾曼生物工程有限公司
|
2024-12-11 | |
¥3850 |
VIP3年
|
湖北魏氏化學試劑股份有限公司
|
2024-12-20 | |
¥1660 |
VIP3年
|
TargetMol中國(陶術生物)
|
2024-12-12 | |
¥7269.90 |
VIP1年
|
上海阿拉丁生化科技股份有限公司
|
2024-11-29 |